Ülke: Avustralya
Dil: İngilizce
Kaynak: APVMA (Australian Pesticides and Veterinary Medicines Authority)
PHENYLBUTAZONE
MAVLAB PTY. LTD.
phenylbutazone(769g/kg)
ORAL GRANULES, PELLETS
PHENYLBUTAZONE ANALGESIC Active 1.0 g/sa
100x1.3g/s; 130g; Sachet
VM - Veterinary Medicine
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
MUSCULOSKELETAL SYSTEM
ANALGESIC | ANTI-INFLAMMATORY AGENT | MUSCULOSKELETAL CONDITIONS | ANTIPYRETIC | ARTHRITIS | ARTHROSIS | BONE SORENESS | BRUISING | BURSITIS | COLIC | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE RELAXANT | MUSCLE SORENESS | OSTEITIS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SEDATIVE | SPASMOLYTIC | SPRAINS | STRAINS | TENDON AND LIGAMENT SPRAINS | TENDON SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE | TRAUMATIC SWELLING
Poison schedule: 4; Withholding period: WHP: MEAT WITHHOLDING PERIOD (HORSES) NOT TO BE USED in horses intended for h uman consumption; Host/pest details: HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [ANALGESIC, ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; As an analgesic and anti-inflammatory in the treatment of musculoskeletal disorders in horses.NOT TO BE USED in horses intended for human consumption
Registered
2023-07-01
Batr.h"o:
PRESCRIPTION
ANIMAL
REMEDY
KEEPOUT
Of
THE REACH OF CHILDREN
FOR
ANIMAL
TREATMENT ONLY
BEAUTAMAV
TASTELESS
GRANULES
ANALGESIC
AND
ANTI·INFLAMMATORY
ACTIVE
lONlTITUENT:
169g/kg
(lgll.Jg)
PHENYLBUTAZONE
As
an analgesic and anti-inflammatory
in the
treatment
of musculoskeletal
disorders in horses.
130g
lABEL
100% SIZE
APVMA
APPROVED
LABEL
copy
DIRECTIONS FOR USE,
HORSES:
450'"
bodyw";Xht
2.6g
atfint
followed
by
I.lg
d.ily
for
4
d.y.
or
as
djf!CI~d
by
v~terinary
surgeon.
"11
be
well
miud
with
a
little
dry
bran
or
oats.
HEAT
WITHHOLDING
PERIOD:
NOT
TO
BE USED
in
hones
that
may be slaulhter'l!d for human consumption.
STORAGE:
Store
below
lOOC
(Room
Temperature)
in
closed
original
rnmainer,
DISPO~
Dispose
of
empty
(amainer
by
wrapping
in
paper.
pl1cing
in
planic
bag
and
puttjn~
in
rarbage.
APVHAAPPROYAl
NO:
56419/13M)604
AUSTRALIAN
OWNED
LABEL IMAGE PROUDLY SUPPLIED BY
INFOPEST@DPI.QLD.GOV.AU
AUSTRALIAN OWNED
DISPOSAL:
DisflOlt
of
empty
containtr
by
wrapping
i.
paptr,
placing
i.
~astic
bag
and
putti.g
in
prilagt.
PRESCRIPTION
ANLW.ILEMEDY
KEEP
our
OF
REACH
OF
0IIUIIlEN
FOR
AIIMAL
T1IEA1MIMT
ON.Y
BEAUTAMAV
TASTELESS
GRANULES
ANALGESIC
AND
ANTI-INFLAMMATORY
ACTIVE
CONsnruENT:
Eadlsachft
contli
. .
:
Tasteless
611.ul"
tquinltnt
to
PHENYLBUTAZONE
Ig
As an analgesic and
anti-inflammatory
in
the
treatment
of
musculoskeletal
disorders in horses.
DIRECNONS
FOR
USE:
HORSES:
450'"
BODYWEIGHT
2
sachetl
at
f
m
100Iowtd
by
I
sachtt
daily
for
4
daY'
Dr
as
diRCltd
by
"It\trinary
IU'lfDn.
"ar
be
well
mixtd
wid1
a
littlt
dry
bl1.or
oatL
MEAT WITHHOLDING PERIOD:
(HOllES)
Not
to
be
ultd
in
ho
.....
i.ttndtd
for
human
consumption.
STORAGE:
Ston
below
lO·C
(~
Temptl1turt)
i.
doltd
ori£inal
cDlttai.er.
I
I>PVMA
AflpnMOl
Number. 56419/100IlI0604
~
LABEL
IS
100%
SIZE
LABEL
SIZE:
LOOMM
X
90MM
100
X
1.3
SACHETS
LABEL
APVMA
APPROVED
_LABEL_
copy
-
DIR!0I0HS
FOR
USE,
ll11rsK:
4S0ku
bod.yweiQhl
2
sorhm
CIl
finl
followed
by
I
50
Belgenin tamamını okuyun
MAVLAB PTY LTD Date of Issue: October 2007 MATERIAL SAFETY DATA SHEET BEAUTAMAV GRANULES Page 1 of 4 MSDS version: 3 Date of Revision: October, 2007 Update of section: All sections SECTION 1 IDENTIFICATION OF THE MATERIAL AND SUPPLIER Product (material) name: Beautamav Tasteless Granules Analgesic And Anti-Inflammatory Other names: None allocated Recommended use: Used as an aid in the treatment of osteoarthritis, bursitis, rheumatism and painful inflammatory conditions in dogs. Supplier Details: Mavlab Pty Ltd ACN 068 507 148 33 Rowland Street SLACKS CREEK QLD 4127 Contact Person: Dr Paul Ross Emergency Telephone: (07) 3808 1399 Facsimile: (07) 3808 4328 SECTION 2 HAZARDS IDENTIFICATION This product is not classified as dangerous goods under the Australian Dangerous Goods Code but is classified as hazardous according to the classification criteria of NOHSC:1008(2004), Approved Criteria For Classifying Hazardous Substances and the National Code of Practice for the Preparation of Material Safety Data Sheets 2 nd Edition [NOHSC:2011(2003)]: Poisons Schedule: S4 Hazard classification: Harmful (Xn) Risk phrase: R22 – Harmful if swallowed Safety phrase: None allocated Health Effects Swallowed: Nausea, vomiting, epigastric distress, diarrhoea, oedema due to salt retention, skin rashes, vertigo, headache, and blurred vision may occur following large doses of Phenylbutazone. Considered an unlikely route of entry in commercial/industrial environments. Eye: Moderate irritant to eyes in powdered state. Skin: Not considered to be an irritant in tablet form. Inhaled: If powdered may cause severe irritation of mucous membranes, nose, eyes and throat. SECTION 3 COMPOSITION/INFORMATION ON INGREDIENTS Ingredients Cas No. Proportion Phenylbutazone 50-33-9 < 50.0% Starch-Maize 9005-25-8 < 35.0% Cellulose-Powdered 9004-34-6 < 10.0% Sodium Lauryl Sulphate 9004-82-4 < 5.0% Sodium Silico-Aluminate 1344-00-9 < 2.0% SECTION 4 FIRST AID MEASURES The following First Aid directions have been set by the Office of Chemical Safety (OCS) of th Belgenin tamamını okuyun